BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26216816)

  • 1. Management of Low-Stage Testicular Seminoma.
    Pearce SM; Liauw SL; Eggener SE
    Urol Clin North Am; 2015 Aug; 42(3):287-98. PubMed ID: 26216816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bilateral Testicular Germ Cell Tumors in the Era of Multimodal Therapy.
    Kopp RP; Chevinsky M; Bernstein M; Bosl G; Motzer R; Bajorin D; Feldman D; Carver BS; Sheinfeld J
    Urology; 2017 May; 103():154-160. PubMed ID: 27816603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors for tumor recurrence in patients with clinical stage I seminoma undergoing surveillance--protocol for a systematic review.
    Kunath F; Spek A; Jensen K; Zengerling F; Schmidt S
    Syst Rev; 2015 Dec; 4():182. PubMed ID: 26684760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of AUC7 adjuvant carboplatin in patients with stage I seminoma: systematic review of the literature.
    Siracusano S; Diminutto A; Porcaro AB; Cerruto MA; Artibani W
    Tumori; 2018; 104(2):83-87. PubMed ID: 27791233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of surveillance versus adjuvant treatment for patients with stage-I seminoma: a single-center experience.
    Akdag G; Alan O; Dogan A; Yuksel Z; Yildirim S; Kinikoglu O; Kudu E; Surmeli H; Odabas H; Yildirim ME; Turan N
    World J Urol; 2023 Aug; 41(8):2201-2207. PubMed ID: 37351618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-agent carboplatin AUC10 in metastatic seminoma: A multi-centre UK study of 216 patients.
    Alifrangis C; Sharma A; Chowdhury S; Duncan S; Milic M; Gogbashian A; Agarwal S; Sahdev A; Wilson P; Harland S; Stoneham S; Lockley M; Rustin G; Oliver T; Berney D; Shamash J
    Eur J Cancer; 2022 Mar; 164():105-113. PubMed ID: 33041185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of tumour size and rete testis invasion in progression free survival of our patients with stage i testicular seminoma. A retrospective observational study of a reference hospital center and literature review.
    Yáñez-Castillo YM; Melgarejo-Segura MT; Gutiérrez-Tejero F; Arrabal-Martín M
    Actas Urol Esp (Engl Ed); 2023 Dec; 47(10):654-660. PubMed ID: 37355209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pure seminoma: a review and update.
    Boujelbene N; Cosinschi A; Boujelbene N; Khanfir K; Bhagwati S; Herrmann E; Mirimanoff RO; Ozsahin M; Zouhair A
    Radiat Oncol; 2011 Aug; 6():90. PubMed ID: 21819630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testicular seminoma and non-seminoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up.
    Oldenburg J; Berney DM; Bokemeyer C; Climent MA; Daugaard G; Gietema JA; De Giorgi U; Haugnes HS; Huddart RA; Leão R; Sohaib A; Gillessen S; Powles T; ;
    Ann Oncol; 2022 Apr; 33(4):362-375. PubMed ID: 35065204
    [No Abstract]   [Full Text] [Related]  

  • 10. Patterns of Relapse in Australian Patients With Clinical Stage 1 Testicular Cancer: Utility of the Australian and New Zealand Urogenital and Prostate Cancer Trials Group Surveillance Recommendations.
    Conduit C; Lewin J; Weickhardt A; Lynam J; Wong S; Grimison P; Sengupta S; Pranavan G; Parnis F; Bastick P; Campbell D; Hansen AR; Leonard M; McJannett M; Stockler MR; Gibbs P; Toner G; Davis ID; Tran B; Kuchel A
    JCO Oncol Pract; 2023 Nov; 19(11):973-980. PubMed ID: 37327464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SEOM clinical guidelines for diagnosis and treatment of testicular seminoma (2010).
    Aparicio J; Sastre J; Germà JR; Isla D
    Clin Transl Oncol; 2011 Aug; 13(8):560-4. PubMed ID: 21821490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second cancer risk and mortality in men treated with radiotherapy for stage I seminoma.
    Horwich A; Fossa SD; Huddart R; Dearnaley DP; Stenning S; Aresu M; Bliss JM; Hall E
    Br J Cancer; 2014 Jan; 110(1):256-63. PubMed ID: 24263066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The increasing burden of testicular seminomas and non-seminomas in adolescents and young adults (AYAs): incidence, treatment, disease-specific survival and mortality trends in the Netherlands between 1989 and 2019.
    van der Meer DJ; Karim-Kos HE; Elzevier HW; Dinkelman-Smit M; Kerst JM; Atema V; Lehmann V; Husson O; van der Graaf WTA
    ESMO Open; 2024 Feb; 9(2):102231. PubMed ID: 38244349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International patterns and trends in testicular cancer incidence, overall and by histologic subtype, 1973-2007.
    Trabert B; Chen J; Devesa SS; Bray F; McGlynn KA
    Andrology; 2015 Jan; 3(1):4-12. PubMed ID: 25331326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance as a safe and effective option for treatment of stage I seminoma.
    Quaresma V; Henriques D; Marconi L; Lorigo J; Ferreira AM; Jarimba R; Nunes P; Figueiredo A; Parada B
    Arch Ital Urol Androl; 2023 Sep; 95(3):11513. PubMed ID: 37668558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic impact of treatment centralization in patients with testicular germ cell tumors: analysis of hospital-based cancer registry data in Japan.
    Suzuki S; Nagumo Y; Kandori S; Kojo K; Nitta S; Chihara I; Shiga M; Ikeda A; Kawahara T; Hoshi A; Negoro H; Bryan MJ; Okuyama A; Higashi T; Nishiyama H
    Int J Clin Oncol; 2024 Mar; 29(3):318-324. PubMed ID: 38265529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contemporary management of early stage testicular seminoma.
    Aydin AM; Zemp L; Cheriyan SK; Sexton WJ; Johnstone PAS
    Transl Androl Urol; 2020 Jan; 9(Suppl 1):S36-S44. PubMed ID: 32055484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost analysis of adjuvant management strategies in early stage (stage I) testicular seminoma.
    Cox JA; Gajjar SR; Lanni TB; Swanson TA
    Res Rep Urol; 2015; 7():1-7. PubMed ID: 25610815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surveillance of stage I seminoma-evidence-based guideline for clinical practice!].
    Schrader M
    Urologie; 2023 Sep; 62(9):958-960. PubMed ID: 37322370
    [No Abstract]   [Full Text] [Related]  

  • 20. Seminoma subtypes differ in the organization and functional state of the immune microenvironment.
    Savelyeva AV; Medvedev KE
    3 Biotech; 2023 Mar; 13(3):110. PubMed ID: 36875959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.